News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Arrowhead Pharmaceuticals, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Deals
Promising Hep B Drug Makes SoCal’s Arrowhead Pharma a Pretty Target for Gilead and Other Big Companies
April 15, 2016
·
2 min read
Deals
Novartis AG Unloads RNAi Portfolio to Arrowhead Research Corporation for $35 Million
March 5, 2015
·
3 min read
Deals
Arrowhead Research Corporation Soars on Rumor of Gilead Sciences, Inc.'s Interest
December 31, 2014
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
November 18, 2024
·
9 min read
Press Releases
Arrowhead Pharmaceuticals to Webcast 2024 Fiscal Year End Results
November 6, 2024
·
4 min read
Press Releases
Arrowhead Pharmaceuticals to Participate in Upcoming November 2024 Conferences
November 4, 2024
·
6 min read
Press Releases
Arrowhead Pharmaceuticals Launches New Disease Awareness Campaign, ‘We’ll Get There Soon,’ to Inspire Hope for the Rare Disease Community Affected by Familial Chylomicronemia Syndrome
November 4, 2024
·
6 min read
Press Releases
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - October 14, 2024
October 15, 2024
·
3 min read
Press Releases
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Initiate Phase 1/2a Study of ARO-INHBE for the Treatment of Obesity
September 23, 2024
·
6 min read
Drug Development
Arrowhead Pharmaceuticals Reports Successful Topline Results for Plozasiran from the Pivotal Phase 3 PALISADE Study in Patients with Familial Chylomicronemia Syndrome
June 3, 2024
·
10 min read
Biotech Beach
Arrowhead Pharmaceuticals to Participate in Upcoming June 2024 Conferences
May 31, 2024
·
5 min read
Drug Development
Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia
May 29, 2024
·
9 min read
Drug Development
Arrowhead Pharmaceuticals Presents New Phase 2 Data of Plozasiran in Patients with Mixed Hyperlipidemia
May 28, 2024
·
10 min read
